Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

crawled time : 12:00    save search

Beamr and NVIDIA team up to accelerate adoption of the newest video standard - AV1
Published: 2024-02-12 (Crawled : 12:00) - globenewswire.com
BMR | $5.12 -7.25% -7.81% 750K twitter stocktwits trandingview |
n/a
| | O: 187.68% H: 475.62% C: 63.92%
NVDA | News | $795.49 4.4% 3.8% 59M twitter stocktwits trandingview |
Electronic Technology
| | O: 0.65% H: 2.77% C: -0.48%

nvidia
Tempest Adopts Limited Duration Stockholder Rights Plan
Published: 2023-10-11 (Crawled : 12:00) - globenewswire.com
TPST | $3.25 4.84% 4.62% 390K twitter stocktwits trandingview |
Manufacturing
| | O: 787.87% H: 358.69% C: 358.69%


Tempest Releases New Data Demonstrating Superiority of TPST-1120 Arm Across Multiple Study Endpoints in Randomized First-Line HCC Study
Published: 2023-10-11 (Crawled : 12:00) - globenewswire.com
TPST | $3.25 4.84% 4.62% 390K twitter stocktwits trandingview |
Manufacturing
| | O: 787.87% H: 358.69% C: 358.69%

tpst-1120 arm study
Endo, Inc. Announces Proposed Private Offering of Senior Secured Notes
Published: 2024-04-08 (Crawled : 12:00) - prnewswire.com
ENDPQ | News | $0.0007 -50.0% 1K twitter stocktwits trandingview |
n/a
| | O: -90.0% H: 300.0% C: 300.0%

offering
Applied UV Announces Acquisition of the Airocide(R) Technology Platform for Airborne Pathogen Reduction
Published: 2021-02-09 (Crawled : 12:00) - biospace.com/
AUVI | $0.5822 -10.77% -12.07% 280K twitter stocktwits trandingview |
Health Technology
| | O: 73.75% H: 297.56% C: 119.0%

acquisition platform
Candel Therapeutics Announces Positive Interim Data from Randomized Phase 2 Clinical Trial of CAN-2409 in Non-Metastatic Pancreatic Cancer
Published: 2024-04-04 (Crawled : 12:00) - globenewswire.com
CADL | $5.55 7.35% 6.85% 580K twitter stocktwits trandingview |
| | O: 26.87% H: 276.85% C: 215.27%

can-2409 positive cancer pancreatic trial therapeutics
Patient with Candida krusei Infection in Matinas BioPharma’s Oral MAT2203 Expanded Access Program Achieves Complete Clinical Resolution
Published: 2023-10-11 (Crawled : 12:00) - globenewswire.com
MTNB | $0.18 -4.1% 0.44% 1.4M twitter stocktwits trandingview |
Health Technology
| | O: 74.26% H: 229.51% C: 137.32%

mat2203 infection program
Endo Announces First Patient Enrolled in Registry of Dupuytren's Contracture
Published: 2023-06-26 (Crawled : 12:00) - biospace.com/
ENDPQ | News | $0.0007 -50.0% 1K twitter stocktwits trandingview |
n/a
| | O: -50.0% H: 200.0% C: 100.0%


IGEN Networks Corporation secures GSA Multiple Award Schedule Contract with State and Federal Governments
Published: 2021-12-03 (Crawled : 12:00) - prnewswire.com
IGEN | $0.0002 -50.0% 170K twitter stocktwits trandingview |
Manufacturing
| | O: 0.0% H: 197.14% C: 137.14%

contract
Pharvaris Reports Third Quarter 2022 Financial Results and Provides Business Update
Published: 2022-12-08 (Crawled : 12:00) - globenewswire.com
PHVS | $20.69 7.99% 7.39% 51K twitter stocktwits trandingview |
| | O: 66.93% H: 184.96% C: 173.51%

financial update results
Pharvaris Announces Positive Top-line Phase 2 Data from RAPIDe-1 Study of PHVS416 for the On-Demand Treatment of HAE Attacks
Published: 2022-12-08 (Crawled : 12:00) - globenewswire.com
PHVS | $20.69 7.99% 7.39% 51K twitter stocktwits trandingview |
| | O: 66.93% H: 184.96% C: 173.51%

phvs416 treatment positive study
BrewBilt Manufacturing Sales For 1st Quarter of 2023 Indicate Growth
Published: 2023-05-11 (Crawled : 12:00) - globenewswire.com
BBRW | $0.0001 -50.0% 1.1M twitter stocktwits trandingview |
Retail Trade
| | O: 11.76% H: 178.95% C: 5.26%

sales indicate growth
South Korea NFT Market Intelligence and Future Growth Dynamics Databook Report 2022: Big Names Enter the NFT Space to Remain Competitive as Traditional Marketing Agencies Face a Decrease in Demand
Published: 2023-01-09 (Crawled : 12:00) - prnewswire.com
CRCW | $0.0015 27.78% 8.5M twitter stocktwits trandingview |
Information
| | O: -51.17% H: 159.0% C: 95.0%

space report growth market
PROOF Acquisition Corp I Stockholders Approve Previously … – Marketscreener.com
Published: 2023-11-29 (Crawled : 12:00) - spacfeed.com
PACI M | $3.77 298.67% 330 twitter stocktwits trandingview |
n/a
| | O: 8.22% H: 150.9% C: 129.46%

acquisition
Quetta Acquisition Corporation Announces the Separate Trading of … – Marketscreener.com
Published: 2023-11-29 (Crawled : 12:00) - spacfeed.com
PACI M | $3.77 298.67% 330 twitter stocktwits trandingview |
n/a
| | O: 8.22% H: 150.9% C: 129.46%

corporation acquisition
FT Due Diligence Series – Add-on acquisitions: forging a way for M&A – Lexology
Published: 2023-11-29 (Crawled : 12:00) - spacfeed.com
PACI M | $3.77 298.67% 330 twitter stocktwits trandingview |
n/a
| | O: 8.22% H: 150.9% C: 129.46%

series
Ohmyhome Announces Signing of Memorandum of Understanding With Ohmyhome Property Inc. to officially expand into the Philippines Market
Published: 2023-05-15 (Crawled : 12:00) - globenewswire.com
OMH | $0.54 10.2% 9.26% 200K twitter stocktwits trandingview |
| | O: 23.62% H: 149.78% C: 35.32%

market
Veru’s Novel COVID-19 Drug Candidate Reduces Deaths by 55% in Hospitalized Patients in Interim Analysis of Phase 3 Study; Independent Data Monitoring Committee Halts Study Early for Overwhelming Efficacy
Published: 2022-04-11 (Crawled : 12:00) - biospace.com/
LLY | News | $731.33 0.69% 0.0% 2.3M twitter stocktwits trandingview |
Health Technology
| | O: 0.45% H: 0.21% C: -1.32%
VERU | $1.27 -3.05% -3.15% 1.4M twitter stocktwits trandingview |
Health Technology
| | O: 37.7% H: 143.24% C: 105.01%

covid-19 drug sabizabulin phase 3
Tempest to Participate in William Blair 2021 Biotech Focus Conference
Published: 2021-07-09 (Crawled : 12:00) - globenewswire.com
TPST | $3.25 4.84% 4.62% 390K twitter stocktwits trandingview |
Manufacturing
| | O: 0.38% H: 137.61% C: 48.81%

pest biotech iot conference
Invivyd Announces Positive Initial Results from Ongoing CANOPY Phase 3 Pivotal Clinical Trial Investigating VYD222 for the Prevention of COVID-19
Published: 2023-12-18 (Crawled : 12:00) - globenewswire.com
IVVD | $2.2 -4.35% -4.55% 1.4M twitter stocktwits trandingview |
Manufacturing
| | O: 23.93% H: 133.17% C: 77.72%

vyd222 covid-19 positive ongoing trial results
Gainers vs Losers
75% 25%

Top 10 Gainers
MTTR | News M | $4.78 174.71% 63.6% 72M twitter stocktwits trandingview |

AGBA | $2.565 105.2% 51.27% 200M twitter stocktwits trandingview |
Finance

MLEC | $2.44 74.29% 42.62% 78M twitter stocktwits trandingview |
n/a

EDBL | News | $6.28 67.02% 40.13% 16M twitter stocktwits trandingview |

ATGL | $2.91 48.81% 32.8% 180K twitter stocktwits trandingview |

ZAPP | $0.2175 47.16% 32.05% 16M twitter stocktwits trandingview |
n/a

ONFO | $0.6075 38.38% 27.74% 7.3M twitter stocktwits trandingview |
n/a

VIVK | $1.48 38.32% 27.7% 530K twitter stocktwits trandingview |
Professional, Scientific, and T...

MNTS | $0.5 35.69% 26.3% 4.8M twitter stocktwits trandingview |

SDIG A | $3.635 35.13% 26.0% 1M twitter stocktwits trandingview |


Your saved searches
Save your searches and get alerts when important news are released.